DePuy Synthes Spine today announced the launch of the ACIS™ Anterior Cervical Interbody Spacer System (ACIS System), a comprehensive set of spacers and instrumentation for anterior cervical discectomy and fusion (ACDF). The announcement was made here at the North American Spine Society (NASS) 27th annual meeting, where the company is featuring the ACIS System alongside the ZERO-P® VA...
Morgan Technical Ceramics participating in revolutionary DARPA research on high density feed-throughs for medical devicesOctober 23, 2012 3:46 pm | by Morgan Technical Ceramics | News | Comments
Morgan Technical Ceramics announces that it has been awarded a contract to participate in a Defense Advanced Research Projects Agency (DARPA) project with the Biomimetic Microelectronics Systems Centers at the University of Southern California. The project will develop biocompatible hermetic coatings, high density ceramic feed-throughs, and hermeticity test chips for biomedical microsystems applications.
Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple StudiesOctober 23, 2012 11:44 am | by Medtronic | News | Comments
For the treatment of long lesions and small vessels –– two challenging characteristics of coronary artery disease commonly found in patients with diabetes –– the Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) delivered successful clinical results, according to new data presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
Ventana Scientists to reveal latest advancements in Multiplexing Gene and Protein Targets for Personalized Medicine and Breast Cancer Testing at Pathology Visions 2012October 23, 2012 7:01 am | by The Associated Press | News | Comments
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, announced today that two of its leading Digital Pathology scientists will present the latest advancements in digital pathology multiplexing and algorithm assisted breast cancer testing at the Pathology Visions Conference in ...
A device created by leading Israeli/American tactical and rescue gear company Agilite that allows soldiers to carry an injured comrade on their backs has accidentally found an entirely new market sector. Nicknamed the “Human Backpack", the Injured Personnel Carrier or IPC is the brainchild of Israeli/American firm Agilite.
Vascular Solutions, Inc. today announced that it has launched the R-Band radial hemostasis compression device in the United States. Vascular Solutions is the exclusive distributor of the R-Band device in the U.S. under an agreement entered into with Lepu Medical Technology (Beijing) Co., Ltd., the developer and manufacturer of the device.
“Implantable devices can save lives and decrease mortality, they are not a luxury” said Professor Angelo Auricchio, President of the European Heart Rhythm Association (EHRA) of the ESC at the ICD for Life Summit which concluded in Belgrade, Serbia, today. “In the face of the impressive rise in cardiovascular related mortality in Central and Eastern Europe, we need to implement a structured approach...
ECA Medical Instruments Launches New Single-Procedure Torque-Limiting Instruments and Kits for Orthopaedic SurgeonsOctober 22, 2012 8:00 am | by The Associated Press | News | Comments
NEWBURY PARK, Calif.--(BUSINESS WIRE)--Oct 22, 2012--ECA Medical Instruments, the leading designer and manufacturer of single-procedure torque-limiting surgical instruments and kits to the medical industry and surgeons worldwide, announced today the introduction of new instruments and kits for...
When it came to designing a multi-leaf collimator (MLC) device, ViewRay took on the challenge to produce an end product that would be more accurate than others on the market. ViewRay collaborated with Maxon Precision Motors for critical components, including a custom motherboard, motors, encoders, gearheads, and individual motor control modules, according to an engineering team member.
Catheter balloons are an important device for a variety of cardiovascular treatments. However, their manufacture can be a complicated process that, if completed wrong, can lead to waste and excess costs. This article highlights a number of innovative technologies that are being offered to help balloon manufacturers ensure their products are defect-free the first time.
Today, U.S. Sen. Tom Carper and U.S. Rep. John Carney (both D-Del) announced $4.6 million in funding from the National Cancer Institute at the National Institutes of Health for the Community Clinical Oncology Program (CCOP). CCOP is a network for testing and validating medical interventions against cancer, and for delivering the benefits of scientific discovery to the public and community physicians.
Carefully applying electricity to the brain can reduce tremors and involuntary movements associated with Parkinson’s disease and a wide range of other conditions, and now a new compilation of major research findings and clinical recommendations is available to help guide referring physicians and other clinicians whose patients might benefit from the therapy.
I tried hard to find a topic other than the coming medical device excise tax to write about, however, either my brain didn’t have any more room to fit another topic or there’s just not that much else going on in the medical device industry (which is much less likely). I was also hesitant to write the column because, unlike with the web, there is a period of time that passes from the moment I complete the column until the time it is published and mailed where the content is out of my hands while outside forces can wreak havoc on the topic and the timing of its appearance.
It’s not the journey, it’s the destination. In the case of interventional cardiovascular devices, both the journey and the destination are vital. These devices need to navigate the tortuous pathways of the vasculature in order to access and treat complex distal lesions. Getting there isn’t always easy.
When a manufacturer picks up a cardiovascular device, they literally hold someone’s life. There is no room for flaws in the quality of this product, or any other in the cardiovascular realm. These devices are shrinking, while becoming increasingly advanced—more intricate parts achieve more complex functions, within a surface area that leaves only enough space for perfection. So the case has never been greater for quality assurance. Conducting risk analysis through variation analysis software can satisfy it.
Medtronic, Inc. (NYSE: MDT), today announced the Japanese regulatory approval and launch of the Advisa DR MRI™ SureScan™ pacing system. The Advisa MRI system is the first and only MR-Conditional pacemaker available to patients in Japan, the world’s second largest market for medical devices.
High-performance coatings are being used across just about every device sector and on a variety of devices. Coatings can make components and the devices themselves stronger, safer, and more cost effective. This article looks at PVDF coatings and the array of benefits they offer when used on orthopedic tools.
As medical devices migrate from the hospital to the patient’s home or workplace, two concepts will become increasingly important: manageability and security. Remote medical devices must often provide continuous care, regardless of their location. Consequently, IT teams will need to manage and control the devices remotely...
Foster Corporation, a leader in custom medical polymers, reports increased interest in implantable medical device applications by polymer suppliers. While risk mitigation remains a primary concern, increased acceptance and application of polymers by device manufacturers for temporary and permanent implants presents opportunities for growth for performance polymers.
Ceretec Inc., Medical Device and Pharmaceutical Product Innovators, Introduces NO-Diff, a Nitric Oxide Lung Diffusion Gas MixtureOctober 17, 2012 11:21 am | by PRNewswire | News | Comments
Ceretec, Inc. today announced that it has introduced an FDA-listed nitric oxide gas product (NO-Diff™ Nitric Oxide 800 ppm Lung Diffusion Mixture) for use in membrane diffusing capacity (DLNO) testing in pulmonary function laboratories in the U.S.
By growing new retinal cells to replace those that have malfunctioned, scientists hope to one day create and fuse entire layers of fresh cells –– a synthetic patch akin to a contact lens –– as a treatment for age-related macular degeneration, the top cause of visual impairment among people over 60.
The inappropriate use or misuse of antibiotics was reported by 9 of 10 infection control officers and laboratory personnel in a nationwide survey of 218 hospitals. Problems cited include unnecessary antibiotic use and the use of weaker broad-spectrum agents when 'targeted,' bacteria-specific antibiotics would be more effective.
Three in 10 patients receiving a kidney transplant require readmission to the hospital within 30 days of discharge following surgery, according to a Johns Hopkins analysis of six years of national data.
A new study led by the Research Institute of the McGill University Health Centre (RI MUHC) is the first to show that hepatitis C rapid and point of care tests with a quick turnaround time are highly accurate and reliable as conventional first-line laboratory tests.
bioMérieux and Thermo Fisher Scientific Inc., the world leader in serving science, announced they have renewed their non-exclusive, long-term, royalty-bearing agreement for Procalcitonin (PCT) testing. The PCT biomarker test is the gold standard for the early detection of sepsis in critically ill patients.